CIK 0001390478 · Non-accelerated filer<br>Smaller reporting company
SELLAS Life Sciences Group, Inc.
Sign in to watch- Ticker
- SLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 6462005278
- Business address
- 7 TIMES SQUARE, SUITE 2503, NEW YORK, NY, 10036
- Former names
- GALENA BIOPHARMA, INC., Galena Biopharma, Inc., RXI PHARMACEUTICALS CORP
- 8-K Event Other events
- 8-K Event Delisting notice
- S-4 Deal Registration Statement - Business Combination
- 8-K Event Regulation FD disclosure · Other events
- 425 Deal Prospectus/Communication re Business Combination
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · Other events
- 10-Q Report Quarterly Report
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Results of operations
- NT 10-Q Other NT 10-Q
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Regulation FD disclosure
- 8-K Event Material agreement · Executive or director change · Regulation FD disclosure · Other events
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Unregistered share sale · Other events
- EFFECT Other Notice of Effectiveness
- POS AM Other Post-effective Amendment for Registration Statement
- 8-K Event Material agreement
- 4 Insider Changes in Ownership
Page 26 of 64 · 1,276 filings